The formation of 3-hydroxy-4-methoxyphenylalanine and 3-hydroxy-4-methoxyphenethylamine in plasma during L-DOPA therapy in patients with Parkinson's disease.

Authors	T Ishimitsu, S Hirose, K Asahara, M Imaizumi
Journal	Chemical & pharmaceutical bulletin (Chem Pharm Bull (Tokyo)) Vol. 32 Issue 8 Pg. 3320-2 (Aug 1984) ISSN: 0009-2363 [Print] Japan
PMID	6518609 (Publication Type: Journal Article)
Chemical References	Methyltyrosines 3-hydroxy-4-methoxyphenethylamine Tyrosine Levodopa 3-methoxytyrosine Dopamine
Topics	Aged Dopamine (analogs & derivatives, blood) Humans Levodopa (therapeutic use) Methyltyrosines (blood) Parkinson Disease (blood, drug therapy) Tyrosine (analogs & derivatives)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!